NasdaqCM - Delayed Quote USD

Capricor Therapeutics, Inc. (CAPR)

5.04 +0.22 (+4.56%)
At close: April 24 at 4:00 PM EDT
5.34 +0.30 (+5.95%)
Pre-Market: 8:06 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
25,178.07
25,178.07
2,551.47
244.90
310.25
Operating Expense
49,255.93
49,255.93
32,248.85
21,183.34
14,000.22
Operating Income
-24,077.86
-24,077.86
-29,697.38
-20,938.44
-13,689.97
Other Income Expense
1,790.32
1,790.32
677.85
915.92
32.94
Pretax Income
-22,287.54
-22,287.54
-29,019.53
-20,022.52
-13,657.03
Net Income Common Stockholders
-22,287.54
-22,287.54
-29,019.53
-20,022.52
-13,657.03
Diluted NI Available to Com Stockholders
-22,287.54
-22,287.54
-29,019.53
-20,022.52
-13,657.03
Basic EPS
-0.83
-0.83
-1.18
-0.87
-0.88
Diluted EPS
-0.83
-0.83
-1.18
-0.87
-0.88
Basic Average Shares
26,778.36
26,778.36
24,552.69
23,089.32
15,571.06
Diluted Average Shares
26,778.36
26,778.36
24,552.69
23,089.32
15,571.06
Total Operating Income as Reported
-24,077.86
-24,077.86
-29,697.38
-20,938.44
-13,689.97
Total Expenses
49,255.93
49,255.93
32,248.85
21,183.34
14,000.22
Net Income from Continuing & Discontinued Operation
-22,287.54
-22,287.54
-29,019.53
-20,022.52
-13,657.03
Normalized Income
-24,010.20
-24,010.20
-29,506.80
-20,390.24
-13,689.97
EBIT
-24,077.86
-24,077.86
-29,697.38
-20,938.44
-13,689.97
EBITDA
-23,008.98
-23,008.98
-29,164.25
-20,692.75
-13,546.08
Reconciled Depreciation
1,068.88
1,068.88
533.13
245.70
143.89
Net Income from Continuing Operation Net Minority Interest
-22,287.54
-22,287.54
-29,019.53
-20,022.52
-13,657.03
Total Unusual Items Excluding Goodwill
1,722.66
1,722.66
487.27
367.72
32.94
Total Unusual Items
1,722.66
1,722.66
487.27
367.72
32.94
Normalized EBITDA
-24,731.64
-24,731.64
-29,651.52
-21,060.46
-13,579.02
12/31/2020 - 2/13/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ACXP Acurx Pharmaceuticals, Inc.
2.0300
-0.49%
 
BNTC Benitec Biopharma Inc.
6.72
-2.04%
 
ALRN Aileron Therapeutics, Inc.
4.9300
+3.79%
 
MDNAF Medicenna Therapeutics Corp.
1.3900
+21.93%
 
HOOK HOOKIPA Pharma Inc.
0.8500
+11.11%
 
ELDN Eledon Pharmaceuticals, Inc.
1.9700
-8.80%
 
NGENF NervGen Pharma Corp.
1.5300
0.00%
 
CYCC Cyclacel Pharmaceuticals, Inc.
2.2999
+28.49%
 
ABEO Abeona Therapeutics Inc.
3.1700
-7.04%
 
ANL Adlai Nortye Ltd.
13.55
+0.37%